Русский / English
Enter the query
News
Press Center
phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru
Contacts
06.09.2018
In 2018, Petrovax Pharm’s pharmaceutical complex in Moscow Region marked its 10th anniversary. The company has commemorated the event by manufacturing the first batches of Grippol®Quadrivalent and making a presentation of the third production line for API as well as suppository and tablet dosage forms.
More
06.08.2018
In July 2018, Petrovax Pharm received Marketing Authorization No. LP-004951 for Grippol® Quadrivalent, a 4-valent inactivated subunit adjuvanted vaccine designed for prevention of influenza. It is the most advanced flu vaccine in the world that employs an antigen sparing technology and has a high preventive activity and safety.
More Topics Petrovax Pharm
16.07.2018
The event took place within the framework of the educational project «We and Media». Participants of the round table discussed ways of fighting dangerous infectious diseases and the role of the media in the popularization of the vaccine prophylaxis.
More Topics Petrovax Pharm / vaccine prophylaxis / quadrivalent vaccine
19.06.2018
Andrey Bougrov, Senior Vice President of MMC Norilsk Nickel and board member of the RSPP, chaired a joint meeting of the RSPP’s Committee on Corporate Relations and the National Council on Corporate Governance (NSKU) Working Group on Improving Corporate Law. Participants discussed the draft bill «On Amendments to the Federal Law ‘On Countering the Illegal Use of Insider Information and Market Manipulation and on Amending Certain Legislative Acts of the Russian Federation’.»
More Topics Russian Union of Industrialists and Entrepreneurs / RSPP / RUIE
11.06.2018
The rating is put together annually by Extel, a British company that studies the global investment climate.
More Topics Norilsk Nickel